|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||
| Current assets: | |||||||||
| Cash and cash equivalents | |||||||||
| Investments and cash held in Trust Account | |||||||||
| Total current assets | |||||||||
| Noncurrent assets: | |||||||||
| Investments and cash held in Trust Account | |||||||||
| Total assets | |||||||||
| Liabilities and Stockholders' Equity: | |||||||||
| Current liabilities: | |||||||||
| Accounts payable and accrued expenses | |||||||||
| Franchise tax accrual | |||||||||
| Accrued offering costs | |||||||||
| Common stock to be redeemed, 9,284,472 shares at $10.00 as of September 30, 2015 | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriter fee | |||||||||
| Total liabilities | |||||||||
| Common stock subject to possible redemption; 11,573,940 shares at $10.00 as of December 31, 2014 | |||||||||
| Stockholders’ equity: | |||||||||
| Preferred stock, $.0001 par value; 1,000,000 shares authorized; none issued | |||||||||
| Common stock, $.0001 par value, authorized 400,000,000 shares; 3,125,000 and 4,051,060 shares issued and outstanding (excluding 9,284,472 and 11,573,940 shares subject to possible redemption) at September 30, 2015 and December 31, 2014, respectively | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders’ equity (deficit) | |||||||||
| Total liabilities and stockholders’ equity (deficit) |
Loading...
